Allergan Aesthetics, an AbbVie company, announced on April 14 that New York entrepreneur and television personality Erin Lichy is sharing her recent breast augmentation journey using Natrelle breast implants. Lichy, a mother of four, said she hopes to encourage open discussion about aesthetic procedures by detailing her decision-making process and post-surgery experience.
The topic of transparency in cosmetic surgery is gaining attention as more individuals seek information about their options. By publicly sharing her story, Lichy aims to support other women considering similar procedures. “Motherhood and breastfeeding changed my body in ways I didn’t fully expect, and I found myself wanting to feel more like me again,” said Erin Lichy. “I didn’t originally consider breast implants because I was looking for an understated result, but after sharing my aesthetic goals with board-certified plastic surgeon Dr. Ira Savetsky, we chose Natrelle implants. It was a very educational conversation. We talked about projection, profile, the safety of the implant and how they would look on my body. I’m thrilled with my results, and I’m sharing my experience to help other women feel more confident to explore their own options.”
Nicole Mowad-Nassar, President of Global Allergan Aesthetics and Senior Vice President at AbbVie said: “Every woman’s aesthetic journey is unique. Erin’s transparency and willingness to share her story fosters connection for other women.” Mowad-Nassar also said: “Honest conversations are the first step in helping women who may be interested in breast augmentation feel empowered to schedule a consultation and learn more.” As part of this partnership with Natrelle, Lichy’s experiences will be shared across social media platforms.
Natrelle offers five profiles and three gummy gel cohesivities among its smooth breast implant options—a product line built on a fifty-year history in breast aesthetics—and features a ten-year clinical safety profile supported by clinical trials according to company data cited in the release.
Patients inspired by these stories can participate in the Faces of Natrelle Testimonial Program by submitting testimonials for possible inclusion on brand channels.
AbbVie delivers products to patients in over 175 countries worldwide according to the official website. The company employs more than 55,000 people globally according to the official website and maintains operations with staff present in over 70 countries according to the official website. AbbVie develops therapies for over 75 conditions each year serving approximately 60 million people according to the official website, focusing its research efforts on areas such as immunology, oncology and neuroscience within the biopharmaceutical sector according to the official website. The company’s stated goal is discovering advanced therapies that address major health challenges while advancing future treatments according to the official website.
The press release notes that while Natrelle breast implants have been used safely for many years under medical supervision—including both silicone- and saline-filled models—patients should discuss potential risks such as complications or additional surgeries with their physicians.
